• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症参数可预测低病死率地区男性 COVID-19 患者的死亡结局 - 一项基于人群的登记研究。

Inflammation parameters predict fatal outcome in male COVID-19 patients in a low case-fatality area - a population-based registry study.

机构信息

Division of Infectious Diseases, Inflammation Center, Helsinki University Hospital, Helsinki, Finland.

Department of Otorhinolaryngology-Head and Neck Center, Helsinki University Hospital, Helsinki, Finland.

出版信息

Infect Dis (Lond). 2022 Aug;54(8):558-571. doi: 10.1080/23744235.2022.2055786. Epub 2022 Mar 30.

DOI:10.1080/23744235.2022.2055786
PMID:35353030
Abstract

BACKGROUND

Male sex predicts case-fatality in SARS-CoV-2 (COVID-19) - a phenomenon linked to systemic inflammation. We compared sex-related associations of inflammation parameters and outcome in a population-based setting with low case-fatality prior to wide use of immunosuppressives.

METHODS

A population-based quality registry with laboratory-confirmed COVID-19 cases of specialized hospitals of the Capital Province of Finland were analysed to compare inflammatory parameters by sex during the first COVID-19 wave February-June 2020.

RESULTS

Altogether, 585 hospitalized patients (54% males) were included. Males required more often intensive care unit (ICU) treatment (26.9 17.5%) and had higher 90-d case-fatality (14.9 7.8%) compared with females. Highest association with case-fatality in males was seen for high neutrophil counts (median; interquartile range) (8.70; 7.10-9.10 5.60; 3.90-7.80) (E9/l), low monocyte (0.50; 0.20-1.50 0.70; 0.50-0.90) (E9/l) and lymphocyte (0.90; 0.70-1.40 vs. 1.50; 1.10-2.00) (E9/l) counts, and high levels of d-dimer (3.80; 1.80-5.30 . 1.10; 0.60-2.75) (mg/l) and C-reactive protein (CRP) (190; 85.5-290 77.0; 49.0-94.0) (mg/l). In females, low lymphocyte (0.95; interquartile range 0.60-1.28 1.50; 1.10-2.00) (E9/l) and thrombocyte counts (196; 132-285 325; 244-464) (E9/l) and high CRP values (95.0; 62.0-256 . 66.0; 42.5-89.0) (mg/l) were associated with case-fatality. In multivariable analysis for males, lymphocyte cut-off 0.85 (E9/l) (OR 0.02; 95% CI 0.002-0.260), d-dimer cut-off 1.15 (mg/l) (OR 7.29; 1.01-52.6) and CRP cut-off 110 (mg/l) (OR 15.4; 1.87-127) were independently associated with case-fatality. In female multivariable analysis, CRP cut-off 81 (mg/l) (OR 7.32; 1.44-37.2) was the only inflammatory parameter associated with case-fatality.

CONCLUSIONS

COVID-19 results in higher inflammation parameter levels in male female patients irrespective of outcome. This study suggests that low lymphocyte, high d-dimer and high CRP cut-off values may serve as potential markers for risk stratification in male patients.

摘要

背景

男性在严重急性呼吸综合征冠状病毒 2 型(COVID-19)中的病死率较高,这一现象与全身炎症有关。在广泛使用免疫抑制剂之前,我们在一个病死率较低的人群中比较了炎症参数与性别相关的关系和结局。

方法

分析芬兰首都地区专科医院的基于人群的 COVID-19 病例质量登记处,以比较 2020 年 2 月至 6 月第一波 COVID-19 期间男性和女性的炎症参数。

结果

共纳入 585 例住院患者(54%为男性)。与女性相比,男性更常需要入住重症监护病房(26.9%比 17.5%),90 天病死率更高(14.9%比 7.8%)。在男性中,与病死率最高相关的是高中性粒细胞计数(中位数;四分位距)(8.70;7.10-9.10比 5.60;3.90-7.80)(E9/L)、低单核细胞(0.50;0.20-1.50比 0.70;0.50-0.90)(E9/L)和淋巴细胞(0.90;0.70-1.40比 1.50;1.10-2.00)(E9/L)计数,以及高水平的 D-二聚体(3.80;1.80-5.30比 1.10;0.60-2.75)(mg/L)和 C 反应蛋白(CRP)(190;85.5-290比 77.0;49.0-94.0)(mg/L)。在女性中,低淋巴细胞(0.95;四分位距 0.60-1.28比 1.50;1.10-2.00)(E9/L)和血小板计数(196;132-285比 325;244-464)(E9/L)以及高 CRP 值(95.0;62.0-256比 66.0;42.5-89.0)(mg/L)与病死率相关。在男性的多变量分析中,淋巴细胞截断值 0.85(E9/L)(OR 0.02;95%CI 0.002-0.260)、D-二聚体截断值 1.15(mg/L)(OR 7.29;1.01-52.6)和 CRP 截断值 110(mg/L)(OR 15.4;1.87-127)与病死率独立相关。在女性多变量分析中,CRP 截断值 81(mg/L)(OR 7.32;1.44-37.2)是唯一与病死率相关的炎症参数。

结论

无论结局如何,COVID-19 都会导致男性和女性患者的炎症参数水平升高。本研究表明,低淋巴细胞、高 D-二聚体和高 CRP 截断值可能是男性患者风险分层的潜在标志物。

相似文献

1
Inflammation parameters predict fatal outcome in male COVID-19 patients in a low case-fatality area - a population-based registry study.炎症参数可预测低病死率地区男性 COVID-19 患者的死亡结局 - 一项基于人群的登记研究。
Infect Dis (Lond). 2022 Aug;54(8):558-571. doi: 10.1080/23744235.2022.2055786. Epub 2022 Mar 30.
2
Male predominance in disease severity and mortality in a low Covid-19 epidemic and low case-fatality area - a population-based registry study.男性在低新冠疫情和低病死率地区疾病严重程度和死亡率方面占优势 - 一项基于人群的登记研究。
Infect Dis (Lond). 2021 Oct;53(10):789-799. doi: 10.1080/23744235.2021.1936157. Epub 2021 Jun 8.
3
[Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].2019冠状病毒病患者D-二聚体浓度与炎症因子或器官功能的关系
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 May;32(5):559-563. doi: 10.3760/cma.j.cn121430-20200414-00518.
4
Risk Factors of Fatal Outcome of Hospitalized Patients with COVID-19.COVID-19 住院患者死亡结局的危险因素。
Discov Med. 2021 May-Jun;31(164):121-127.
5
[Correlation between early inflammation indicators and the severity of coronavirus disease 2019].[2019年冠状病毒病早期炎症指标与疾病严重程度的相关性]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Feb;33(2):145-149. doi: 10.3760/cma.j.cn121430-20200515-00387.
6
Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.COVID-19 感染患者的死亡率:预测结局的生化标志物及其截断值。
J Coll Physicians Surg Pak. 2022 Jan;32(1):37-41. doi: 10.29271/jcpsp.2022.01.37.
7
Routine laboratory testing to determine if a patient has COVID-19.进行常规实验室检测以确定患者是否感染新冠病毒。
Cochrane Database Syst Rev. 2020 Nov 19;11(11):CD013787. doi: 10.1002/14651858.CD013787.
8
Longitudinal changes in inflammatory biomarkers among patients with COVID-19: A nationwide study in Iceland.冰岛全国性研究:COVID-19 患者炎症生物标志物的纵向变化。
Acta Anaesthesiol Scand. 2022 Sep;66(8):969-977. doi: 10.1111/aas.14109. Epub 2022 Jul 29.
9
C-reactive protein and clinical outcomes in patients with COVID-19.C 反应蛋白与 COVID-19 患者的临床结局。
Eur Heart J. 2021 Jun 14;42(23):2270-2279. doi: 10.1093/eurheartj/ehaa1103.
10
Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.利用 C 反应蛋白与白蛋白比值对重症 COVID-19 患者的疾病进展进行早期预测。
Dis Markers. 2021 Dec 3;2021:6304189. doi: 10.1155/2021/6304189. eCollection 2021.

引用本文的文献

1
COVID-19 disease severity in language minorities in Finland: an observational population-based register study.芬兰语言少数群体中新冠肺炎的疾病严重程度:一项基于人群的观察性登记研究。
BMC Public Health. 2025 May 29;25(1):1978. doi: 10.1186/s12889-025-23160-x.
2
Prognostic value of C-reactive protein levels in pulmonary infections: A systematic review and meta-analysis.C反应蛋白水平在肺部感染中的预后价值:一项系统评价和荟萃分析。
Medicine (Baltimore). 2025 Mar 21;104(12):e41722. doi: 10.1097/MD.0000000000041722.
3
Status of Inflammatory and Coagulation Factors in COVID-19 and Its Relation with the Disease Severity.
新型冠状病毒肺炎中炎症因子和凝血因子的状态及其与疾病严重程度的关系
Tanaffos. 2023 Apr;22(4):389-394.
4
A deep learning model for predicting COVID-19 ARDS in critically ill patients.用于预测危重症患者中新型冠状病毒肺炎急性呼吸窘迫综合征的深度学习模型。
Front Med (Lausanne). 2023 Jul 25;10:1221711. doi: 10.3389/fmed.2023.1221711. eCollection 2023.
5
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients.验证T淋巴细胞亚群指数(TLSI)作为预测未接种疫苗的住院COVID-19患者死亡率的评分指标
Biomedicines. 2022 Nov 2;10(11):2788. doi: 10.3390/biomedicines10112788.